NCT02350140

Brief Summary

Early accurate diagnosis is one of the first crucial steps in care for infants born to HIV-infected mothers. Early initiation of antiretroviral therapy (ART) relies upon early diagnosis and results in significant reductions in infant morbidity and mortality. The investigators recently concluded a successful randomized controlled trial in Kenya entitled, "Improving uptake of early infant diagnosis of HIV for prevention of mother-to-child HIV transmission (PMTCT): a randomized trial of a text messaging intervention" (ClinicalTrials.gov # NCT01433185). In this study, text messages developed using a behavioral theoretical framework significantly improved maternal attendance at post-partum clinic appointments and rates of testing to facilitate early infant diagnosis of HIV in a selected population and controlled setting. Understanding the effectiveness of this intervention (and its limitations) in a real-world, routine-care setting represents the next step in the translational pathway to public health impact. The investigators therefore now propose a cluster randomized, stepped wedge trial in 20 clinics operated by the Kenyan Ministry of Health in the Nyanza region of Kenya and use the Reach, Effectiveness, Adoption, Implementation, and Maintenance (REAIM) framework to understand the effectiveness of the text messaging to improve testing (TextIT) intervention. Our specific aims are:

  1. 1.To determine the effect of TextIT on maternal attendance at postpartum clinic visits during the randomized stepped-wedge rollout of the intervention.
  2. 2.To determine the effect of TextIT on virological infant HIV testing within eight weeks after birth during the randomized stepped-wedge rollout of the intervention.
  3. 3.To determine the costs and cost-effectiveness of TextIT. The investigators will estimate the cost per patient and per health gain achieved (disability-adjusted life year, DALY) comparing TextIT to current standard care.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,508

participants targeted

Target at P75+ for not_applicable hiv

Timeline
Completed

Started Jan 2015

Longer than P75 for not_applicable hiv

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

January 19, 2015

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 29, 2015

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

May 8, 2018

Status Verified

November 1, 2017

Enrollment Period

2.9 years

First QC Date

January 19, 2015

Last Update Submit

May 5, 2018

Conditions

Keywords

HIVPrevention of mother-to-child HIV transmissionPMTCTmobile health (mHealth)mobile phonetext messagingshort message services (SMS)

Outcome Measures

Primary Outcomes (3)

  • Postpartum retention in prevention of mother-to-child HIV transmission programs

    Maternal attendance at postpartum clinic visits within eight weeks after delivery

    1 year

  • Infant HIV testing by DNA PCR within 8 weeks after birth

    1 year

  • Cost-effectiveness of TextIT

    1 year

Secondary Outcomes (7)

  • Overall public health impact

    1 year

  • Place of delivery and skilled birth attendance

    1 year

  • A combined outcome for stillbirth (after 28 weeks of pregnancy) or infant death within the first two months after a live birth

    1 year

  • Birth weight

    1 year

  • Reported infant feeding option

    1 year

  • +2 more secondary outcomes

Study Arms (2)

Text messaging from beginning

EXPERIMENTAL

Half of the health facilities will be randomly allocated to receive the TextIT intervention during the first time period (six months), while the other half to continue with current standard care (first step)

Other: Text messaging from beginning

Text messaging after 6 months of control

ACTIVE COMPARATOR

Half the facilities will receive standard of care for six months (first time period). After the first time period, the these facilities will then also receive the TextIT intervention (second step)

Other: Text messaging after 6 months of control

Interventions

Registered women will then receive up to 14 text messages as follows: weeks 28, 30, 32, 34, 36, 38, 39, and 40 during the third trimester of pregnancy; weeks 1, 2, 3, 4, 5, and 6 after delivery.Participants at facilities receiving TextIT will have the option to call or send text messages to a designated clinic phone, to which a clinic nurse will respond. Participants will also have an option to request a call from the clinic by sending a free "call back" text message to the designated clinic phone at any time.

Also known as: TextIT
Text messaging from beginning

After six months of standard care, women at control clinics will be registered to receive the text messaging intervention with up to 14 text messages as follows: weeks 28, 30, 32, 34, 36, 38, 39, and 40 during the third trimester of pregnancy; weeks 1, 2, 3, 4, 5, and 6 after delivery.

Text messaging after 6 months of control

Eligibility Criteria

Age14 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Are ≥18 years or emancipated minors;
  • Are at 28 weeks gestation or greater (or have delivered on the day of enrollment);
  • Provide informed consent

You may not qualify if:

  • Women who report sharing phones but have not disclosed their HIV status to the person with whom the phone is shared.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kenya Medical Research Institute, Family AIDS Care and Education Services

Kisumu, Nyanza, Kenya

Location

Related Publications (3)

  • Odeny TA, Bukusi EA, Cohen CR, Yuhas K, Camlin CS, McClelland RS. Texting improves testing: a randomized trial of two-way SMS to increase postpartum prevention of mother-to-child transmission retention and infant HIV testing. AIDS. 2014 Sep 24;28(15):2307-12. doi: 10.1097/QAD.0000000000000409.

    PMID: 25313586BACKGROUND
  • Odeny TA, Newman M, Bukusi EA, McClelland RS, Cohen CR, Camlin CS. Developing content for a mHealth intervention to promote postpartum retention in prevention of mother-to-child HIV transmission programs and early infant diagnosis of HIV: a qualitative study. PLoS One. 2014 Sep 2;9(9):e106383. doi: 10.1371/journal.pone.0106383. eCollection 2014.

    PMID: 25181408BACKGROUND
  • Odeny TA, Hughes JP, Bukusi EA, Akama E, Geng EH, Holmes KK, McClelland RS. Text messaging for maternal and infant retention in prevention of mother-to-child HIV transmission services: A pragmatic stepped-wedge cluster-randomized trial in Kenya. PLoS Med. 2019 Oct 2;16(10):e1002924. doi: 10.1371/journal.pmed.1002924. eCollection 2019 Oct.

Study Officials

  • Thomas A Odeny, MBChB, MPH

    Kenya Medical Research Institute

    PRINCIPAL INVESTIGATOR
  • Scott R McClelland, MD MPH

    University of Washington

    STUDY CHAIR
  • Craig R Cohen, MD MPH

    University of California, San Francisco

    STUDY CHAIR
  • Elizabeth Bukusi, MBCHB PHD

    Kenya Medical Research Institute

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Scientist

Study Record Dates

First Submitted

January 19, 2015

First Posted

January 29, 2015

Study Start

January 1, 2015

Primary Completion

December 1, 2017

Study Completion

December 1, 2018

Last Updated

May 8, 2018

Record last verified: 2017-11

Locations